In the four trading sessions between July 14 and July 17, SpaceX stock lost roughly $100 billion in market value. It recorded its first-ever close below the $135 IPO price on July 16, at $131.11. The next day it fell a further 5.43 percent to $123.99 — its sixth consecutive losing session, its ninth decline in ten sessions, and a level roughly 42 to 45 percent below the June 16 post-IPO peak of $225.64.
The event that was supposed to interrupt this sequence did not happen. Starship Flight 13, scheduled for the evening of July 16, aborted automatically at T-0 after four of the Super Heavy booster’s 33 Raptor engines failed to ignite during the startup sequence. On Sunday, July 19, SpaceX announced a new target: Thursday, July 23. Later the same day, Elon Musk posted that the launch would occur on Friday — contradicting his own company’s statement by a day. As of Monday morning, the correct date is genuinely unclear.
Between the July 17 close and the August 6 earnings date, something structurally important has also happened that received far less coverage than the price decline itself: the $175.50 performance trigger — the mechanism gating an additional 456 million shares of insider supply — has become mathematically unreachable. That sounds like good news for the stock. The full mechanics suggest something more uncomfortable: the market has spent July repricing SPCX from a story about upside triggers to a story about downside supply, and the only scheduled event left between here and the lockup is a rocket launch that has now slipped twice.
The Week That Broke the Setup
When we documented the first intraday breach of the IPO price on July 16, the structure of the situation was a countdown: a stock at its floor, a binary catalyst that evening, and a dual earnings-and-lockup event three weeks out. Every element of that structure has since resolved in the adverse direction.
The July 15 intraday breach became a July 16 closing breach at $131.11 — the close being the level that index funds, volatility models, and margin calculations actually reference. The evening catalyst became an ignition failure: the abort tripped automatically after engine start began, and Musk subsequently confirmed that two Raptors would be removed and replaced, with Reuters attributing roughly $100 billion of market-value loss to the abort and its aftermath. The following session compounded the damage — the 5.43 percent decline on July 17 was aggravated by a broad technology selloff, but SPCX fell roughly three and a half times as hard as the Nasdaq-100 that day, which is what a de-risking market does to its highest-beta positions.
The pattern matters more than any single number. A stock that was being held for its catalysts is now being sold despite them. The July 3 analysis argued that once the Nasdaq-100 inclusion mechanics were spent, SPCX would have to find buyers on fundamental terms. Three weeks later, the market’s answer on those terms is legible in the tape: nine declines in ten sessions, a 23 percent loss since the inclusion date itself, and a Monday pre-market print of $125.48 that recovers barely a fifth of Friday’s fall.
How the Trigger Died, and Why That Is Not Good News
The $175.50 performance condition works as follows: if SPCX closes above that level on five of the ten trading sessions before the Q2 earnings report, an additional tranche of approximately 456 million shares becomes eligible for early release alongside the base lockup expiration. At $124, satisfying the condition would require a sustained move of roughly 42 percent within the next two weeks — not a rally, but a full reversal of the entire post-inclusion decline, held for a week. No mechanism visible on the calendar produces that. The trigger is dead.
The first-order reading is bullish: 456 million shares that might have hit the market in August now will not. Supply that was conditional on strength never materializes in weakness. This is true, and it is the reading that dip-buyers appear to be acting on.
The second-order reading is what the trigger’s death says about how the listing was engineered, and what remains behind it. Performance-triggered unlocks exist to let insiders sell into strength — they are a reward structure that converts a rising price into liquidity. When the trigger was set at $175.50 against a $135 IPO price, the implied expectation was that the stock would spend late July 30 percent above its offering level. The design assumed the FOMO carry-through would persist at least into the first earnings report. The listing-psychology dynamics we documented before the IPO — demand pulled forward by scarcity mechanics and narrative momentum — were not an accident of the market. They were the environment the offering’s architecture was built for. That environment lasted five weeks.
And the base lockup does not care about the trigger. Up to 1.37 billion shares — against a traded float that has been roughly 3 to 5 percent of shares outstanding since the IPO — become eligible for sale in the days following the August 6 earnings report, unconditionally. The trigger’s death removes the incremental 456 million; it does nothing to the 1.37 billion. What it does change is the price environment into which that base supply arrives. Insiders who might have been patient sellers at $175 face a different decision at $124: some will defer, hoping for recovery; others — particularly early employees and funds with distributed cost bases far below the IPO price — remain profitable sellers at almost any level above single digits. The lockup was always the supply event. It is now a supply event arriving at the bottom of the range rather than the top.
The Arithmetic of 1.37 Billion Shares
The scale of the August 6 event deserves to be stated in numbers rather than adjectives, because the numbers are unusual even by the standards of large lockup expirations.
Since the IPO, SPCX’s traded float has been roughly 3 to 5 percent of shares outstanding. Every price on the chart — the $225.64 peak, the $135 offering level, Friday’s $123.99 — has been set by trading in that sliver. The base lockup releases up to 1.37 billion shares in the days after the earnings report. Depending on where in the 3-to-5-percent range the current effective float sits, that release represents an increase in potentially tradeable supply of several hundred percent — not a marginal loosening but a change in the kind of market the stock trades in.
The standard reassurance about lockups is that eligible supply is not the same as sold supply, and that is correct. Most insiders at most companies do not liquidate at the first opportunity. But the reassurance assumes a normal distribution of holder motivations, and SPCX’s cap table is not normal. It contains venture funds that entered more than a decade ago at costs measured in cents against today’s $124, employees whose equity has been illiquid for years longer than a typical pre-IPO tenure because the company stayed private so long, and secondary-market buyers from the 2021-2024 tender rounds whose cost bases cluster far below the offering price. For the first two groups, $124 is not a disappointing price; it is a liquidity event they have waited a decade for at a multiple of their basis. The question is not whether they are underwater — almost none of them are — but how much of a decade’s deferred selling arrives in the first window that permits it.
Against that supply stands the demonstrated absorption capacity of the current market: a dip-buying constituency that has purchased tens of millions of dollars per week into a decline that has erased tens of billions per week. The two sides of that ledger are not the same order of magnitude. For the lockup to clear without another leg down, either insider selling must be far more restrained than the cap-table incentives suggest, or a new class of institutional buyer must appear at levels the existing institutions have spent July selling. The Q2 report is the only scheduled event that could produce that buyer.
What the Precedents Say About This Phase
The post-inclusion correction phase of this stock ran faster than the Palantir precedent that circulated at inclusion — ten sessions to the IPO floor against Palantir’s multi-month grind after its September 2020 S&P 500 addition. The phase now beginning has its own precedents, and they are worth consulting with the same discipline.
Large-float unlocks into weak tape have a consistent recent history. Facebook’s November 2012 expiration — the closest analogue in scale, roughly 800 million shares against a then-depressed post-IPO price — is remembered for the counterintuitive outcome: the stock rose on the unlock day, because the event was fully priced and the feared supply arrived slower than positioned-for. Snap’s 2017 unlock, by contrast, extended an existing decline for months as insider selling met no institutional bid. The variable that separated the outcomes was not the unlock mechanics; it was whether the company’s next earnings report gave institutions a reason to stand on the bid. Facebook’s did. Snap’s did not.
That is precisely the structure SPCX has stumbled into, with the earnings report and the unlock now fused into the same week. August 6 is not an earnings date followed by a lockup; it is a single event in which the first fundamental disclosure in the company’s public life determines, in real time, whether a decade of deferred insider liquidity meets a bid or a vacuum. The Facebook path and the Snap path both remain open. What has closed, over the past four sessions, is the path in which the stock approaches that event from a position of strength.
The Squeeze Scenario Cuts Both Ways
A 28 percent short interest imposes obligations on the bear case too, and intellectual honesty requires laying them out.
Short positions of that size in a thin float are combustible. A successful Flight 13 on Thursday — clean ascent, V3 deployment, booster performance validating the refly economics JPMorgan keeps asking about — into a stock this heavily shorted could produce a covering rally out of proportion to the news itself. The $25 billion short base has to buy the same thin float it sold, and thin floats amplify in both directions; the mechanics that took the stock from $225 to $124 in five weeks can run in reverse over days. Anyone framing the current setup as a one-way bet has not looked at the borrow.
But a squeeze is a flow event, not a valuation event, and the calendar caps its half-life. Any covering rally this week runs into the same wall every rally faces: fourteen days later, the lockup opens, and a squeezed price is a better exit than a depressed one — for insiders above all. A Flight 13 squeeze that carries SPCX back toward $150 would, perversely, increase the probability of heavy insider selling in the unlock window, because it restores the exit prices the July decline took away. The short base knows this, which is why short interest has held near 28 percent through the decline rather than taking profits: the position is not a bet on the launch failing. It is a bet that whatever the launch does, the supply arrives anyway.
The First Crack in the Sell-Side Wall
Until last week, the post-quiet-period analyst picture was uniform: fourteen initiations, all buy-equivalent, averaging a $187.80 target. The July 16 analysis noted the structural reason to discount that uniformity — underwriting banks initiate positive — and observed that the correction had manufactured the appearance of upside while the absolute targets stood still.
The uniformity is now broken. Piper Sandler initiated coverage at Neutral, citing valuation and the approaching lockup expirations against the thin traded float. One neutral rating among fifteen is not a bearish consensus; it is, however, the first time a covering analyst has declined to endorse the stock, and first cracks in post-IPO coverage walls tend to matter more than their nominal weight, because they license the next dissent. JPMorgan’s aerospace desk, while formally constructive, has focused its questions on the economics of Starship second-stage reuse — the exact variable the Flight 13 program keeps failing to derisk — and has flagged the size of the short base.
That short base is itself now a defining feature of the stock. Short interest stands near 28 percent of the float, off a peak around 31 percent — by available measures the most heavily shorted major new listing on the market, roughly $25 billion in short exposure. The mirror position also exists: ARK Invest bought approximately $16.6 million of the July 15 decline and roughly $36 million across the week, and retail flow has not capitulated. The result is a stock with the highest-conviction disagreement in the market — 28 percent of the float betting on further decline, dip-buyers accumulating, and a valuation near 49 times expected revenue that both sides cite as evidence.
One further datapoint belongs in this ledger. Insider filings over the trailing three months show roughly $1.2 million in sales and zero purchases. The amounts are trivial against SpaceX’s capitalization — most insiders remain locked — but the direction is not. Through a 45 percent drawdown, no insider with discretion has filed a purchase. The people with the most information about the August 6 numbers have, so far, declined to buy the dip that outside capital is buying.
A Catalyst That Keeps Slipping
The July 16 abort was, in engineering terms, unremarkable — engine-out aborts at ignition are what launch control systems exist for, and swapping two Raptors is routine work for a program that manufactures them at scale. The market’s problem is not the abort. It is the sequence: a catalyst that was scheduled for July 16, then slipped to July 20 in early reporting, is now targeted for July 23 by the company and July 24 by its chief executive, in public statements issued hours apart on the same Sunday.
For a normal industrial company, a four-day test-flight slip would be noise. SPCX is not trading as a normal industrial company. It is trading as a narrative stock in a drawdown, and narrative stocks in drawdowns metabolize ambiguity badly. The date confusion is a small thing that reads as a large thing: the single scheduled event standing between the current price and the August 6 earnings report cannot currently be placed on a calendar with confidence. Traders who bought the July 16 launch got an abort; traders positioning for July 20 got a Sunday slip; whoever positions for Thursday may be positioning for Friday.
It is also worth restating what the launch can and cannot do, because the July 16 session demonstrated the asymmetry. A successful Flight 13 — carrying the first twenty Starlink V3 satellites on a suborbital profile — validates hardware and advances the program. It generates no revenue, changes no Q2 number, and unlocks no analyst-model revision beyond sentiment. A second consecutive failure, by contrast, would land on a stock at its all-time low, twelve days before earnings, with the Artemis overhang resurfacing in coverage — NASA’s 2027 crewed-lunar target now publicly at odds with SpaceX’s own earliest-2028 internal timeline. The catalyst’s upside is a sentiment bounce; its downside is thesis damage. That asymmetry, more than any single data point, is what the 28 percent short interest is pricing.
Seventeen Days of Compressed Events
The slip has also done something subtle to the calendar: it has compressed what were three spaced catalysts into a seventeen-day corridor. The launch — Thursday or Friday — now sits less than two weeks before the August 6 earnings report, which itself opens the lockup window. There is no longer a quiet period in which the stock can find a level on its own; every remaining session between now and mid-August sits in the shadow of one event or the next.
Compression changes behavior. Institutions that might have traded the launch and then repositioned for earnings will now set positions once, for the whole corridor. Options positioning into August 6 has to price launch risk and earnings risk and lockup risk in a single expiry structure. And any post-launch rally — the scenario in which Flight 13 succeeds and the stock recovers toward $140 or $150 — runs directly into the question every holder must answer before August 6: is this the level to carry through an earnings report with no precedent and a five-fold float expansion behind it, or the level to exit into?
The July 16 analysis posed the same question for a stock at $135. The market spent the intervening three sessions answering it from $124.
What the Bull Case Now Requires
It is worth stating the recovery path precisely, because it has narrowed to a specific sequence.
First, Flight 13 must fly and succeed this week — a second abort or an in-flight failure removes the only near-term positive catalyst and likely tests the $120 level. Second, the Q2 report on August 6 must beat the projections embedded at the IPO: Starlink subscriber growth at or above trajectory despite Amazon Kuiper’s first year of commercial service, launch-cadence revenue converting on schedule, Starship development costs contained despite a quarter that now includes two high-profile test-flight anomalies and an engine-replacement campaign. Third, the lockup release must be absorbed — insider selling in the days after August 6 must run below the market’s capacity to buy it at prevailing prices, which is a bet on the same dip-buying constituency that has so far been outgunned by the decline.
The Starlink leg carries a detail that connects it back to the launch. Flight 13’s payload — the first twenty Starlink V3 satellites — is not a demonstration cargo. V3 is the hardware generation on which Starlink’s capacity growth, and therefore its subscriber ceiling, depends, and the company’s FCC filing to deploy as many as 100,000 next-generation satellites assumes Starship-class lift to orbit them. Every week of Starship slippage is a week of V3 deployment slippage, at precisely the moment Kuiper is spending its first commercial year converting the customers Starlink cannot yet serve. The launch the market keeps treating as a sentiment event is, on this one dimension, a revenue-timeline event after all — just on a horizon longer than an options expiry.
Each leg is possible. The conjunction is demanding. And the analyst consensus that implies 51 percent upside from $124 — an average target of $187.80 that has not moved while the stock fell 45 percent — requires all three legs to land. Consensus targets that require a parlay are not price forecasts; they are artifacts of initiation-season mechanics awaiting their first revision cycle, and the first revision (Piper’s Neutral) has already arrived.
The bear case requires nothing to happen. That is its structural advantage. The lockup arrives on the calendar whether or not anyone acts; the earnings report discloses whatever the quarter contains; the launch flies when it flies. A short thesis whose catalysts are scheduled is a different instrument from a long thesis whose catalysts must all break favorably — and the 28 percent of the float positioned short reflects exactly that difference.
Where the Series Stands
Across three analyses — July 3, July 16, and today — the trajectory of this listing has followed the listing-psychology template with unusual fidelity. The pre-inclusion rally reversed on schedule. The IPO floor broke on the timeline the float mechanics implied, first intraday, then on a close. The float and lockup architecture we documented when it was first disclosed has moved from a background structural fact to the dominant variable in the stock’s pricing. What began in June as a story about how much enthusiasm a 4 percent float could concentrate has become, in five weeks, a story about how much supply a 45 percent drawdown must absorb.
The next entries in the sequence are fixed: a launch on Thursday or Friday — the date itself currently a matter of public disagreement between SpaceX and its chief executive — and the August 6 report, now seventeen days out. The watch items between now and then: whether the FAA and company notices converge on July 23 or 24; whether the pre-market stabilization near $125 holds through the week or the $120 level gets its test; whether any second analyst follows Piper off the buy wall; and whether a single insider purchase appears in the filings. Four small questions, each with an unambiguous answer in the data when it arrives. The August 6 question is larger, and the market is already pricing its answer: a stock designed to unlock at $175.50 will instead meet its first earnings report, and its first real supply, somewhere near $124.
